Literature DB >> 25744024

Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.

L Wang1,2, S Liu1,3, Y Zhao1, D Liu4, Y Liu4, C Chen4, S Karray5, S Shi1,3,4, Y Jin1,3.   

Abstract

The interplay between osteoblasts and osteoclasts has a crucial role in maintaining bone homeostasis. In this study, we reveal that osteoblasts are capable of inducing osteoclast apoptosis by FAS ligand (FASL)/FAS signaling. Conditional knockout of FASL in osteoblasts results in elevated osteoclast numbers and activity, along with reduced bone mass, suggesting that osteoblast-produced FASL is required to maintain physiological bone mass. More interestingly, we show that osteoblasts from ovariectomized (OVX) osteoporotic mice exhibit decreased FASL expression that results from the IFN-γ- and TNF-α-activated NF-κB pathway, leading to reduced osteoclast apoptosis and increased bone resorption. Systemic administration of either IFN-γ or TNF-α ameliorates the osteoporotic phenotype in OVX mice and rescues FASL expression in osteoblasts. In addition, ovariectomy induces more significant bone loss in FASL conditional knockout mice than in control group with increased osteoclast activity in which the levels of RANKL and OPG remain unchanged. Taken together, this study suggests that osteoblast-induced osteoclast apoptosis via FASL/FAS signaling is a previously unrecognized mechanism that has an important role in the maintenance of bone mass in both physiological conditions and OVX osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25744024      PMCID: PMC4563780          DOI: 10.1038/cdd.2015.14

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  54 in total

1.  Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Authors:  Olivier Micheau; Jürg Tschopp
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

2.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.

Authors:  Stephen J Rodda; Andrew P McMahon
Journal:  Development       Date:  2006-07-19       Impact factor: 6.868

3.  IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.

Authors:  Yuhao Gao; Francesco Grassi; Michaela Robbie Ryan; Masakazu Terauchi; Karen Page; Xiaoying Yang; M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

Review 4.  Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

5.  Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody.

Authors:  Seiji Kamijo; Atsuo Nakajima; Kaori Ikeda; Kazuhiro Aoki; Keiichi Ohya; Hisaya Akiba; Hideo Yagita; Ko Okumura
Journal:  Biochem Biophys Res Commun       Date:  2006-06-23       Impact factor: 3.575

6.  Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.

Authors:  Chen Zhao; Naoko Irie; Yasunari Takada; Kouji Shimoda; Takeshi Miyamoto; Toru Nishiwaki; Toshio Suda; Koichi Matsuo
Journal:  Cell Metab       Date:  2006-08       Impact factor: 27.287

7.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

Authors:  D E Hughes; A Dai; J C Tiffee; H H Li; G R Mundy; B F Boyce
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

9.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

10.  RANKL expression is related to the differentiation state of human osteoblasts.

Authors:  Gerald J Atkins; Panagiota Kostakis; Beiqing Pan; Amanda Farrugia; Stan Gronthos; Andreas Evdokiou; Kate Harrison; David M Findlay; Andrew C W Zannettino
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

View more
  40 in total

1.  A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling.

Authors:  Daniel R Jones
Journal:  Ann Transl Med       Date:  2015-08

2.  Growth-dependent phenotype in FasL-deficient mandibular/alveolar bone.

Authors:  Eva Svandova; Jeremy Sadoine; Barbora Vesela; Amina Djoudi; Herve Lesot; Anne Poliard; Eva Matalova
Journal:  J Anat       Date:  2019-05-30       Impact factor: 2.610

3.  Using three-point bending to evaluate tibia bone strength in ovariectomized young mice.

Authors:  Charles Deckard; Azida Walker; Brent J F Hill
Journal:  J Biol Phys       Date:  2017-01-28       Impact factor: 1.365

Review 4.  DC-STAMP: A Key Regulator in Osteoclast Differentiation.

Authors:  Ya-Hui Chiu; Christopher T Ritchlin
Journal:  J Cell Physiol       Date:  2016-06-14       Impact factor: 6.384

5.  Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling.

Authors:  Qinyu Ma; Mengmeng Liang; Yutong Wu; Ning Ding; Lianli Duan; Tao Yu; Yun Bai; Fei Kang; Shiwu Dong; Jianzhong Xu; Ce Dou
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 6.  Osteoblast-osteoclast interactions.

Authors:  Xiao Chen; Zhongqiu Wang; Na Duan; Guoying Zhu; Edward M Schwarz; Chao Xie
Journal:  Connect Tissue Res       Date:  2017-03-21       Impact factor: 3.417

7.  The W9 peptide inhibits osteoclastogenesis and osteoclast activity by downregulating osteoclast autophagy and promoting osteoclast apoptosis.

Authors:  Yuying Kou; Congshan Li; Panpan Yang; Dongfang Li; Xiong Lu; Hongrui Liu; Minqi Li
Journal:  J Mol Histol       Date:  2021-10-18       Impact factor: 2.611

8.  Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors.

Authors:  Dawei Liu; Xiaoxing Kou; Chider Chen; Shiyu Liu; Yao Liu; Wenjing Yu; Tingting Yu; Ruili Yang; Runci Wang; Yanheng Zhou; Songtao Shi
Journal:  Cell Res       Date:  2018-07-20       Impact factor: 25.617

9.  FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8+ T Cells During Ischemic Stroke.

Authors:  Lizhen Fan; Cun-Jin Zhang; Liwen Zhu; Jian Chen; Zhi Zhang; Pinyi Liu; Xiang Cao; Hailan Meng; Yun Xu
Journal:  Transl Stroke Res       Date:  2020-02-08       Impact factor: 6.829

10.  Hypoxia-inducible factor-2α mediates senescence-associated intrinsic mechanisms of age-related bone loss.

Authors:  Sun Young Lee; Ka Hyon Park; Gyuseok Lee; Su-Jin Kim; Won-Hyun Song; Seung-Hee Kwon; Jeong-Tae Koh; Yun Hyun Huh; Je-Hwang Ryu
Journal:  Exp Mol Med       Date:  2021-04-02       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.